Fusion Pharmaceuticals In... (FUSN)
NASDAQ: FUSN
· Real-Time Price · USD
21.55
0.03 (0.14%)
At close: Jun 03, 2024, 10:00 PM
Fusion Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -33.67M | -28.18M | -17.25M | -25.18M | -24.29M | -24.62M | -24.01M | -19.07M | -19.91M | -17.24M | -19.43M | -26.85M | -17.53M |
Depreciation & Amortization | 361K | 361K | 374K | 337K | 273K | 248K | 242K | 216K | 203K | 184K | 185K | 154K | 111K |
Stock-Based Compensation | 4.52M | 3.25M | 2.99M | 3.05M | 3.15M | 2.78M | 2.7M | 2.74M | 2.63M | 2.37M | 2.37M | 2.15M | 1.72M |
Other Working Capital | 1.89M | 2.14M | -3.27M | 3.27M | 732K | 1.58M | 303K | -1.4M | 2.48M | -416K | -146K | -1.71M | -3.24M |
Other Non-Cash Items | 4.33M | 1.7M | 179K | -552K | -570K | -147K | 1.35M | 386K | 495K | 573K | 683K | 9.2M | 241K |
Deferred Income Tax | -405K | 2.92M | -882K | -696K | -494K | -651K | -1.92M | -253K | -340K | -321K | -257K | 98K | 449K |
Change in Working Capital | 2.35M | 3.01M | -4.25M | 3.46M | -3.5M | 3.02M | 16K | -1.33M | 1.95M | -1.89M | -5.07M | -2.05M | -5.59M |
Operating Cash Flow | -27.31M | -16.94M | -18.84M | -19.58M | -25.43M | -19.36M | -21.63M | -17.32M | -14.97M | -16.33M | -21.51M | -17.31M | -20.6M |
Capital Expenditures | -1.33M | -1.44M | -473K | -710K | -1.22M | -950K | -222K | -375K | -595K | -538K | -160K | -209K | -584K |
Cash Acquisitions | n/a | -48.91M | -13.8M | 25.61M | 23.3M | 41.98M | -37.47M | -10.02M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -118.61M | -56.43M | -38.83M | -70.08M | -62.42M | -89.66M | -25.95M | -32.22M | -17.33M | -15.04M | -25.29M | -66.06M | -66.07M |
Sales Maturities Of Investments | 49.57M | 53.17M | 52.63M | 44.47M | 39.12M | 47.68M | 63.41M | 42.24M | 37.06M | 46.48M | 57.66M | 69.93M | 37.66M |
Other Investing Acitivies | -69.04M | 48.91M | 13.8M | -25.61M | -23.3M | -41.98M | 37.47M | 10.02M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -70.37M | -4.7M | 13.33M | -26.32M | -24.53M | -42.93M | 37.25M | 9.64M | 19.13M | 30.9M | 32.22M | 3.66M | -29M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | 1.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 64.01M | 57.85M | 328K | 24.31M | 59.52M | 131K | 28.91M | 9.99M | 1.71M | -50K | 57K | 210K | 130K |
Financial Cash Flow | 64.01M | 56.22M | 328K | 24.31M | 59.52M | 131K | 28.91M | 9.99M | 1.71M | -50K | 57K | 210K | 130K |
Net Cash Flow | -33.67M | 34.67M | -5.18M | -21.59M | 9.55M | -62.17M | 44.53M | 2.31M | 5.87M | 14.52M | 10.76M | -13.46M | -49.45M |
Free Cash Flow | -28.64M | -18.37M | -19.31M | -20.29M | -26.66M | -20.31M | -21.85M | -17.69M | -15.57M | -16.86M | -21.67M | -17.52M | -21.18M |